Atsushi Ohashi, Masashi Nakatani, Hideo Hori, Shigeru Nakai, Kunihiro Tsuchida, Midori Hasegawa, Naotake Tsuboi. Effects of N-acetyl-L-tryptophan on desorption of the protein-bound uremic toxin indoxyl sulfate and effects on uremic sarcopenia. Therapeutic Apheresis and Dialysis. 2023
Hideo Hori, Kazuyoshi Sakai, Atsushi Ohashi, Shigeru Nakai. Chitin powder enhances growth factor production and therapeutic effects of mesenchymal stem cells in a chronic kidney disease rat model. Journal of Artificial Organs. 2022
Midori Hasegawa, Nobuya Kitaguchi, Hajime Takechi, Kazunori Kawaguchi, Kengo Ito, Takashi Kato, Masao Kato, Norio Nii, Sachie Yamada, Atsushi Ohashi, et al. First-in-human study of blood amyloid β removal from early Alzheimer's disease patients with normal kidney function. Therapeutic Apheresis and Dialysis. 2022. 26. 3. 529-536
Midori Hasegawa, Hiromichi Matsushita, Kensei Yahata, Akira Sugawara, Yoshitaka Ishibashi, Ryoko Kawahara, Yoshifumi Hamasaki, Hitoshi Kanno, Sachie Yamada, Norio Nii, et al. Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell-free and concentrated ascites reinfusion therapy, in a postmarketing clinical study. Therapeutic Apheresis and Dialysis. 2021. 25. 4. 407-414
Atsushi Ohashi, Shigeru Nakai, Hideo Hori, Sachie Yamada, Masao Kato, Shigehisa Koide, Hiroki Hayashi, Naotake Tsuboi, Daijo Inaguma, Midori Hasegawa, et al. Suppression of inflammation during cell-free concentrated ascites reinfusion therapy ( CART ) using a blood purification device. Therapeutic Apheresis and Dialysis. 2020. 24. 5. 511-515
Suppression of inflammation during cell-free concentrated ascites reinfusion therapy (CART) using a blood purification device
(12th World Congress of International Society for Apheresis 40th JSFA 2019)